Home
Home | New Titles | Focus Reports | Custom Research | Browse Catalog  |  About Us |  Contact Us   |  

View Cart  |  Complete Purchase  |  View Wish List  |  My Reading Room  |  Edit Account  |  Purchase History  |  Register  |  Login  
       

Pet Health: Products & Services to 2016

 


 





Study #: 2913
Document Type: Industry Study
Date Published: Jul-2012
Format:
   Full study: PDF
   Section, Pages, Tables and Charts: HTML
Pages: 262
Full Study Price: $5,100.00
       

    

The continuing “humanization” of companion animals and their treatment as family members, plus veterinary technology that adapts techniques from human health care, will spur demand.

US consumer spending to exceed $30 billion in 2016

US consumer spending on pet health products and services is expected to reach $30.9 billion in 2016, with over three-fifths of expenditures accounted for by services. The overall pet population is expected to approach 218 million animals, with 62 percent of US households owning pets. Advances in pet health expenditures will be encouraged by the continuing “humanization” of companion animals and their treatment as family members. Veterinary technology will also continue to adapt diagnostic and treatment techniques from human health care, stimulating value gains for newer, more costly procedures.

Pet insurance spending to post double-digit growth

Pet health services comprise veterinary care, non-veterinary care, and pet insurance. The fastest gains in pet health service spending will remain in pet insurance, with revenues expected to advance more than 11 percent annually through 2016 to $680 million. While penetration rates will remain low, rising spending on veterinary procedures will encourage more pet owners to select insurance coverage to help mitigate costs.

Surgical and non-surgical veterinary care will continue to dominate pet health services, accounting for close to three-quarters of spending. Surgical revenues will remain the larger segment, as these more costly procedures increasingly see technology transfer from human medicine, such as in dialysis and organ transplants. Newly available services typically cost significantly more than established procedures, adding to revenue gains. However, non-veterinary pet care, including boarding and grooming, accounts for significant spending as pet owners opt for services such as “doggy day care” to tend to pets while owners are away at work or on vacation.

Online pharmacies, large retailers, pet superstores to gain market share

At the retail level, consumers are forecast to spend $11.5 billion on pet health products in 2016, supporting $5.6 billion in manufacturers’ level sales. Online pharmacies, pet superstores, and large retailers including Wal-Mart will continue to gain market share over veterinary practices due to significant cost savings, and major retail centers will dedicate more floor space to pet products. The most rapid gains will continue to be in demand for dietary supplements due to an ongoing focus on preventive health care. Further contributing to growth will be increases in age- and weight-related medical conditions among pets, such as arthritis, diabetes, and obesity.

Pharmaceuticals and parasiticides will continue to dominate spending on pet health products, accounting for a combined 63 percent of the market in 2016. While these two product categories will see the largest gains in demand, they will be outpaced by advances for less mature preventive products such as dietary supplements, diagnostics, and prescription food.

Study Scope

This study analyzes the $24.6 billion US pet health industry. It presents historical demand data for the years 2001, 2006 and 2011, and forecasts for 2016 and 2021 by service (e.g., veterinary care, non-veterinary pet care, pet insurance), product (e.g., pharmaceuticals, parasiticides, prescription food, dietary supplements, vaccines, diagnostics), condition (e.g., skin, heart, gastrointestinal, renal, arthritis) and animal (e.g., dogs, cats, birds, small animals).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 27 industry players, including Pfizer, Merial and Bayer.

 










Freedonia Footer Links
Career Opportunities   Press Contact   Partner Programs   User Agreement   Privacy Policy   FAQ’s/Help   Site Map   Study Index




E-mail: info@freedoniagroup.com • telephone: +1 440.684.9600 • fax: +1 440.646.0484      
767 Beta Dr. Cleveland Ohio 44143 USA

Copyright © 2013 - Freedonia - All Rights Reserved